Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lankelma

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Cancer Letters|March 1, 1981
Inhibition of cell growth by N-(phosphonacetyl)-L-aspartate in human and murine cells in vitroA Leyva, H Appel, P Smith, et al.
British Journal of Cancer|July 1, 1990
Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cellsH J Broxterman, H M Pinedo, G J Schuurhuis, et al.
Anticancer Research|July 1, 1983
High uridine phosphorylase activity in human melanoma tumorA Leyva, I Kraal, J Lankelma, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1984
Separation of several 5-fluorouracil metabolites in various melanoma cell lines. Evidence for the synthesis of 5-fluorouracil-nucleotide sugarsG J Peters, E Laurensse, J Lankelma, et al.
Microvascular Research|January 8, 2000
A mathematical model of drug transport in human breast cancerJ Lankelma, R Fernández Luque, H Dekker, et al.
Cancer Research|January 1, 1986
Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymesG J Peters, E Laurensse, A Leyva, et al.
European Journal of Biochemistry|August 22, 2000
Evaluating limited specificity of drug pumps reduced relative resistance in human MDR phenotypesA P Jongsma, A Riethorst, J Lankelma, et al.
Biochemical Pharmacology|September 15, 1994
Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cellsC H Versantvoort, H J Broxterman, J Lankelma, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Measurement of in vitro cellular pharmacokinetics of 5-fluorouracil in human and rat cancer cell lines and rat hepatocytes using a flow-through systemE C Spoelstra, H M Pinedo, H Dekker, et al.
European Journal of Biochemistry|April 1, 1994
The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrateE C Spoelstra, H V Westerhoff, H M Pinedo, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Cancer Letters|March 1, 1981
Inhibition of cell growth by N-(phosphonacetyl)-L-aspartate in human and murine cells in vitroA Leyva, H Appel, P Smith, et al.
British Journal of Cancer|July 1, 1990
Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cellsH J Broxterman, H M Pinedo, G J Schuurhuis, et al.
Anticancer Research|July 1, 1983
High uridine phosphorylase activity in human melanoma tumorA Leyva, I Kraal, J Lankelma, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1984
Separation of several 5-fluorouracil metabolites in various melanoma cell lines. Evidence for the synthesis of 5-fluorouracil-nucleotide sugarsG J Peters, E Laurensse, J Lankelma, et al.
Microvascular Research|January 8, 2000
A mathematical model of drug transport in human breast cancerJ Lankelma, R Fernández Luque, H Dekker, et al.
Cancer Research|January 1, 1986
Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymesG J Peters, E Laurensse, A Leyva, et al.
European Journal of Biochemistry|August 22, 2000
Evaluating limited specificity of drug pumps reduced relative resistance in human MDR phenotypesA P Jongsma, A Riethorst, J Lankelma, et al.
Biochemical Pharmacology|September 15, 1994
Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cellsC H Versantvoort, H J Broxterman, J Lankelma, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Measurement of in vitro cellular pharmacokinetics of 5-fluorouracil in human and rat cancer cell lines and rat hepatocytes using a flow-through systemE C Spoelstra, H M Pinedo, H Dekker, et al.
European Journal of Biochemistry|April 1, 1994
The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrateE C Spoelstra, H V Westerhoff, H M Pinedo, et al.
Pageof 10